Sign inJoin waitlistJoin the waitlist

Bennett Chin

Section Chief · University of Colorado School of Medicine

Credentials: · · · ·

History

University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

Johns Hopkins University School of Medicine
1991–1992
Brigham and Women's Hospital
1990–1991
Methodist Health System Dallas
1987–1990
University of Texas Medical Branch at Galveston School of Medicine
1983–1987

Research

Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Journal of Nuclear Medicine · 2019 · 235 citations
111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction
Nuclear Medicine Communications · 2003 · First of 6 authors · Corresponding · 164 citations
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma
The Journal of Clinical Endocrinology & Metabolism · 2004 · First of 6 authors · Corresponding · 107 citations

Ba Nguyen
7 papers
Jorge Oldan
7 papers · 5 as a fellow
Richard Wahl
7 papers
Abass Alavi
4 papers
AH
Alan Heldman
4 papers
David Bluemke
4 papers
JW
Jonathan Wehrend
4 papers · 3 as a resident
PP
Pavni Patel
4 papers · 4 as a resident
Sreekanth Vemulapalli
4 papers
AC
Ali Civelek
3 papers
DB
Douglas Beall
3 papers · 3 as a resident
Lilja Solnes
3 papers

Grants

Geles: A Novel Imaging Informatics System for Generalizable Lesion Identification in Neuroendocrine Tumors
National Cancer Institute · R21
PI · $388.5K · University of Colorado Denver
2023–2026
Small Animal PET/SPECT/CT Molecular Imaging
National Center for Research Resources · S10
Contact PI · $600K · Duke University
2011–2012
Integrated Center for InVivo Microscopy
National Center for Research Resources · P41
Project lead · $5K · Duke University
2007–2008

Clinical trials

68Ga-PSMA-11 PET in Patients With Prostate Cancer
Principal investigator · Completed · Phase 3
University of Colorado, Denver
2021–2022
Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG
Principal investigator · Completed · Phase 1
Bennett Chin
2009–2011
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Principal investigator · Unknown · Phase 2
Molecular Insight Pharmaceuticals, Inc.
2009–2021